LIPO Lipella Pharmaceuticals
- 0.569
- -0.038-6.26%
Lipella Pharmaceuticals News
Lipella Pharmaceuticals | 8-K: Current report
Lipella Pharmaceuticals | 8-K: Current report
Lipella Pharmaceuticals | 424B5: Prospectus
Lipella Pharmaceuticals | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Lipella Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kaufman Jonathan H
Lipella Pharmaceuticals | 10-Q: Q1 2024 Earnings Report
Lipella Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jonathan H. Kaufman(19.3%)
Lipella Pharmaceuticals | 8-K: Current report
Lipella Pharmaceuticals | 8-K: Current report
Lipella Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Pruchnic Ryan
Lipella Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Yoshimura Naoki
Lipella Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Chancellor Michael B
Lipella Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Birder Lori
Lipella Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kaufman Jonathan H
Lipella Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Johnston Douglas
Lipella Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Cohen Daniel R
Lipella Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Kim Byong
Lipella Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Jonathan H. Kaufman(21.0%)
Lipella Pharmaceuticals | 8-K: Current report
Lipella Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Officer Kaufman Jonathan H
Analysis
Price Target
No Data
